administrative expense to support business expansion. Without the non-recurring profit related to sale of Dusit Princess Korat, core EBITDA was THB 806 million, a 12.3% decrease from 2016. The Company reported net
No. 9 (TFRS 9). Financial instruments under TFRS 9 are classified into 3 stages. For stage 1, TFRS 9 requires ECL allowances based on 12 month expected losses. For Stage 2 and Stage 3, the standard
of Director’s Meeting No.4/2019 held on August 8, 2019 about the expansion of Wattanapat Samui Hospital project, increasing licensed beds from twenty nine beds to no more than 59 licensed beds
the previous quarter. The main supporting factors were the return-to-expansion of export goods, private investment as well as a continual expansion of government expenditure. Meanwhile, the new wave of
No. WPH-SET 9/2019 August 9, 2019 Subject : The expansion of Wattanapat Samui Hospital project To : Director and Manager The Stock Exchange of Thailand Enclosure: The Acquisition and Disposition of
No. WPH-SET 9/2019 August 9, 2019 Subject : The expansion of Wattanapat Samui Hospital project To : Director and Manager The Stock Exchange of Thailand Enclosure: The Acquisition and Disposition of
growth in all major segments together with gross margin expansion. - Q1’20 Revenue from sales grew by 5.0% YoY, amounting to THB 6.7 billion, driven by the growth in all major segments particulary
from Capital Market business operated by KKP Capital Plc. and subsidiaries. Pre-provision operating profit increased by 6.8% yoy driven by the increased in net interest income from loan expansion and
which had average traffic volume in the second quarter of the year 2017 at 47,600 trips/day. For the First Stage Expressway (FES) and the Second Stage Expressway (SES), toll revenue increased from the
third quarter of the year 2017 at 53,100 trips/day. For the First Stage Expressway (FES) and the Second Stage Expressway (SES), toll revenue was similar to the previous year. For the Bang Pa-in - Pak Kret